Skip to main content
AH

AIKON Health

AIKON HEALTH provides a proprietary wearable monitoring device integrated with digital health solutions for personalized heart failure management. This system enables cardiologists and nurses to perform precise medication titration and proactive patient care. The platform utilizes clinically validated digital biomarkers to improve workflow and reduce heart failure patient hospital readmissions.

Eindhoven, The Netherlands4300+ followers
Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Heart failure patients require continuous monitoring of vital signs to manage symptoms and prevent hospital readmissions, but traditional monitoring methods are often cumbersome and lack real-time data insights. Existing solutions may not seamlessly integrate into clinical workflows, hindering effective medication titration and personalized care.

Solution

AIKON Health offers a wearable sensor utilizing ultra-thin, stretchable skin patches for continuous, comfortable monitoring of heart failure patients. The device captures heart-failure-specific parameters, providing healthcare professionals with real-time data to facilitate precise medication adjustments and proactive management. Integrated with digital health solutions, the device improves workflow through continuous monitoring and interoperability with Hospital Information Systems (HIS) and Remote Patient Monitoring (RPM) platforms. Clinically validated digital biomarkers enable early intervention and prediction, potentially reducing hospital readmissions.

Target Audience

The primary target audience includes cardiologists, nurses, and other healthcare professionals involved in the management of heart failure patients, as well as hospitals and remote patient monitoring programs.

Features

  • Ultra-thin, stretchable skin patch for comfortable, long-term wear and improved patient adherence.
  • Continuous monitoring of heart-failure-specific parameters.
  • Integration with HIS/RPM systems for improved interoperability and streamlined workflows.
  • Clinically validated digital biomarkers for early intervention and prediction of adverse events.
This profile is AI-generated and may contain inaccuracies.